Anti-human Siglec-3 / CD33 (LintuzumAb Biosimilar) Size:1 mg 3ml RTU -20°C 9 Counter

3ml RTU -20°C 9 Counter Staining Reagent 5ml RTU RT 10 Differentiation Reagent 6ml RTU RT 11 Mounting Media 5ml RTU RT 12 Control slide (Human kidney) 1 slide RTU RT 13 Datasheet 1 copy

They are designated at type I (slow twitch) and type II (fast twitch)

and operation in complete darkness is unnecessary

CEA was originally described in bile ducts of liver as biliary glycoprotein

Tyramide Signal Amplification (TSA) is an enzymatic detection method that uses horseradish peroxidase (HRP) to label target proteins in situ

Anti-human Siglec-3 / CD33 (LintuzumAb Biosimilar) Size:1 mg 3ml RTU -20°C 9 CounterApplication ELISA, Bioactivity: FACS, Functional assay, Research in vivo Reactivity Human Target Target Name Siglec 3 CD33 Target Uniprot O14793 Overview Catalog# BIO0405SM Product Name Anti human Siglec 3 CD33 (LintuzumAb Biosimilar) Specifications Conjugation None Clone# LintuzumAb Formulation 100 mM Pro Ac 20mM Arg pH 5. 0 Storage For long term storage, the produce should be stored at 20 or lower. Reconstitution Dissolve with sterile ddH2O